Johnson & Johnson seeks emergency use nod for Covid vaccine in India
Johnson & Johnson (JNJ.N) has applied for emergency use approval of its coronavirus vaccine in India, the U.S. pharmaceutical giant said on Friday, moving a step closer to supplying the first single-dose COVID-19 shot to the country. (Reuters)
Other Pharmaceuticals Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma
